AMYOTROPHIC-LATERAL-SCLEROSIS PARKINSONISM-DEMENTIA COMPLEX OF GUAM -QUANTITATIVE NEUROPATHOLOGY, IMMUNOHISTOCHEMICAL ANALYSIS OF NEURONALVULNERABILITY, AND COMPARISON WITH RELATED NEURODEGENERATIVE DISORDERS
Pr. Hof et al., AMYOTROPHIC-LATERAL-SCLEROSIS PARKINSONISM-DEMENTIA COMPLEX OF GUAM -QUANTITATIVE NEUROPATHOLOGY, IMMUNOHISTOCHEMICAL ANALYSIS OF NEURONALVULNERABILITY, AND COMPARISON WITH RELATED NEURODEGENERATIVE DISORDERS, Acta Neuropathologica, 88(5), 1994, pp. 397-404
Amyotrophic lateral sclerosis/parkinsonism-dementia complex (lytico-bo
dig) is a chronic neurodegenerative disorder with high prevalence amon
g the native Chamorro population of Guam. Neuropathological, biochemic
al, and immunohistochemical analyses were performed on a relatively la
rge series of Guamanian cases and compared to Alzheimer's disease case
s. Thioflavin S and antibodies to amyloid beta A4 and tau proteins wer
e used for analysis of pathological changes, and antibodies to the cal
cium-binding proteins parvalbumin and calretinin, and to a nonphosphor
ylated epitope on neurofilament protein to study select neuronal popul
ations. A differential distribution of neurofibrillary tangles was obs
erved in the neocortex of Guamanian cases compared to Alzheimer's dise
ase cases, with much higher lesion counts in supragranular than in inf
ragranular layers. Also, Guamanian cases with predominant parkinsonism
had generally higher neurofibrillary tangle densities than cases with
predominant amyotrophic lateral sclerosis. In addition, there was a c
ertain degree of heterogeneity, qualitatively and quantitatively, in t
he biochemical distribution of tau proteins among Guamanian and Alzhei
mer's disease cases as revealed by Western blot analysis. Previous stu
dies have suggested that the clinical symptomatology observed in patie
nts suffering from Alzheimer's disease is related to the dramatic loss
of specific corticocortically projecting neurons in the neocortex. In
terestingly, a subset of neurofilament-rich pyramidal neurons known to
be dramatically affected in Alzheimer's disease appears to be resista
nt in lytico-bodig. Finally, as in Alzheimer's disease, calcium-bindin
g protein-containing interneurons are not affected. These data suggest
that the set of projection neurons affected in Guamanian cases may no
t correspond to those involved in Alzheimer's disease, and that both d
isorders are characterized by specific patterns of neuronal vulnerabil
ity.